CN104841008B - 一种水凝胶敷料及其制备方法 - Google Patents
一种水凝胶敷料及其制备方法 Download PDFInfo
- Publication number
- CN104841008B CN104841008B CN201510318928.9A CN201510318928A CN104841008B CN 104841008 B CN104841008 B CN 104841008B CN 201510318928 A CN201510318928 A CN 201510318928A CN 104841008 B CN104841008 B CN 104841008B
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- rhizoma atractylodis
- fructus hippophae
- mixed liquor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000004964 aerogel Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 95
- 235000003935 Hippophae Nutrition 0.000 claims abstract description 59
- 241000229143 Hippophae Species 0.000 claims abstract description 59
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 47
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 32
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 27
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 27
- 239000008367 deionised water Substances 0.000 claims abstract description 26
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 26
- 239000012467 final product Substances 0.000 claims abstract description 24
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims abstract description 23
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 20
- 229920001525 carrageenan Polymers 0.000 claims abstract description 20
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 20
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 20
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 20
- 229920000656 polylysine Polymers 0.000 claims abstract description 20
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 16
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims abstract description 16
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 16
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 claims abstract description 16
- 229910021538 borax Inorganic materials 0.000 claims abstract description 16
- 239000001110 calcium chloride Substances 0.000 claims abstract description 16
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 16
- 235000019837 monoammonium phosphate Nutrition 0.000 claims abstract description 16
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 16
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 16
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 16
- 239000011718 vitamin C Substances 0.000 claims abstract description 16
- 235000011148 calcium chloride Nutrition 0.000 claims abstract description 9
- 235000011187 glycerol Nutrition 0.000 claims abstract description 9
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims abstract description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 48
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- 229940044192 2-hydroxyethyl methacrylate Drugs 0.000 claims description 16
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 16
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 claims description 11
- 229920001991 Proanthocyanidin Polymers 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 8
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 8
- 230000018044 dehydration Effects 0.000 claims description 8
- 238000006297 dehydration reaction Methods 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- 238000002481 ethanol extraction Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000013557 residual solvent Substances 0.000 claims description 8
- 238000001256 steam distillation Methods 0.000 claims description 8
- 238000006136 alcoholysis reaction Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000006116 polymerization reaction Methods 0.000 claims description 7
- 239000000341 volatile oil Substances 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 8
- 230000035876 healing Effects 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 2
- -1 hydroxyl ethyl Chemical group 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 description 36
- 206010052428 Wound Diseases 0.000 description 35
- 239000000499 gel Substances 0.000 description 16
- 239000000017 hydrogel Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 241000132011 Atractylodes lancea Species 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 5
- 230000006837 decompression Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 241000208838 Asteraceae Species 0.000 description 2
- 241000132003 Atractylis Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 206010048038 Wound infection Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- FBMORZZOJSDNRQ-GLQYFDAESA-N Atractylenolide III Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@@]1(O)C2=C(C)C(=O)O1 FBMORZZOJSDNRQ-GLQYFDAESA-N 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 241000516289 Atractylodes carlinoides Species 0.000 description 1
- 241000984235 Atractylodes koreana Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001237160 Kallima inachus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028034 Mouth ulceration Diseases 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- 208000006595 Necrotizing Ulcerative Gingivitis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030216 Oesophagitis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010068796 Wound contamination Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000006881 esophagitis Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 201000009862 superficial mycosis Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004154 testing of material Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000008587 ulcerative stomatitis Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510318928.9A CN104841008B (zh) | 2015-06-11 | 2015-06-11 | 一种水凝胶敷料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510318928.9A CN104841008B (zh) | 2015-06-11 | 2015-06-11 | 一种水凝胶敷料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104841008A CN104841008A (zh) | 2015-08-19 |
CN104841008B true CN104841008B (zh) | 2016-10-12 |
Family
ID=53841241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510318928.9A Expired - Fee Related CN104841008B (zh) | 2015-06-11 | 2015-06-11 | 一种水凝胶敷料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104841008B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194724B (zh) * | 2015-09-30 | 2018-03-16 | 苏州蔻美新材料有限公司 | 一种水凝胶敷料的制备方法 |
CN105777820B (zh) * | 2016-03-16 | 2019-03-12 | 天津市医药科学研究所 | 一种用于皮肤创面给药的药用载体及其制备方法、应用 |
CN106075562A (zh) * | 2016-07-29 | 2016-11-09 | 江苏蓝湾生物科技有限公司 | 一种负压伤口治疗用护创液的制备方法 |
KR20190012120A (ko) * | 2017-07-26 | 2019-02-08 | (주)유레 | 히알루론산-칼슘 및 폴리라이신을 포함하는 창상 피복재 및 그 제조 방법 |
CN108273123A (zh) * | 2018-02-28 | 2018-07-13 | 苏州凌科特新材料有限公司 | 一种医用止血促愈合水凝胶敷料及其制备方法 |
CN110227177B (zh) * | 2019-05-23 | 2021-08-03 | 中山市粤美医疗生物科技有限公司 | 一种含角叉菜胶的敷料及其制备方法 |
CN112206093A (zh) * | 2019-07-10 | 2021-01-12 | 广西美丽肤医疗器械有限公司 | 防水透气湿式敷料 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1195489C (zh) * | 1999-01-12 | 2005-04-06 | 内蒙古宇航人化妆品有限责任公司 | 沙棘精华素 |
CN1381275A (zh) * | 2002-03-17 | 2002-11-27 | 胡阿兰 | 一种复合型医用无纺布 |
US7968085B2 (en) * | 2004-07-05 | 2011-06-28 | Ascendis Pharma A/S | Hydrogel formulations |
CN1748801A (zh) * | 2004-10-23 | 2006-03-22 | 赖铁军 | 烧烫伤止痛中药纱布 |
CN101653622A (zh) * | 2009-09-11 | 2010-02-24 | 姚辉 | 双黄连无定形水凝胶药用敷料及其制备方法 |
CN101664564B (zh) * | 2009-09-11 | 2012-10-03 | 姚辉 | 双黄连定形水凝胶药用敷料及其制备方法 |
CN101745139A (zh) * | 2010-01-09 | 2010-06-23 | 褚加冕 | 一种含有透明质酸钠的生物抗菌敷料 |
-
2015
- 2015-06-11 CN CN201510318928.9A patent/CN104841008B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104841008A (zh) | 2015-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104841008B (zh) | 一种水凝胶敷料及其制备方法 | |
CN109078165B (zh) | 一种用于女性私处护理的组合物及其制备方法与应用 | |
CN101920042B (zh) | 一种液体创口贴及制备方法 | |
CN105194719A (zh) | 一种面部创口修复敷料、敷贴及其制备方法 | |
CN104368031A (zh) | 一种医用抗菌敷料及其制备方法 | |
CN102631423B (zh) | 一种用于伤口清洗的护理液 | |
CN105106655A (zh) | 一种修复性烧伤烫伤膏及其制备方法 | |
CN102258804A (zh) | 一种液体创口贴及其制备方法 | |
CN108272723A (zh) | 一种植物抗敏护肤组合物及其应用 | |
CN105920654A (zh) | 一种烧伤科使用的具有抗菌效果的烧伤敷料 | |
CN105596268B (zh) | 一种含杨枸花的可擦拭止痒护肤品 | |
CN104922058A (zh) | 一种魔芋葡甘聚糖抗脚气凝胶剂及其制备方法 | |
Chelu et al. | Aloe vera-based hydrogels for wound healing: properties and therapeutic effects. Gels. 2023; 9: 539 | |
CN105726352A (zh) | 一种魔芋葡甘聚糖婴幼儿爽身粉及其制备方法 | |
CN102716281A (zh) | 一种用于术后伤口清洗的护理液 | |
CN109513035A (zh) | 一种多功能水胶体敷料及其制备方法 | |
CN108403570A (zh) | 对湿疹引起的皮肤瘙痒有改善效果的体用凝露及制备方法 | |
CN1539508A (zh) | 创面修复敷料基质、敷料及制备工艺 | |
CN105363021A (zh) | 促进创面愈合的凝胶 | |
CN104887607A (zh) | 一种魔芋葡甘聚糖痱子膏及其制备方法 | |
CN111040896A (zh) | 一种抗菌消炎美肤手工皂 | |
CN109010520A (zh) | 一种治疗暗疮的药膏及其制备方法 | |
CN105853340A (zh) | 一种护足霜及其制备方法 | |
CN111904887B (zh) | 一种皮肤卫生护理组合物及其在纸尿裤中的应用 | |
CN105497962A (zh) | 具有杀菌止痒功能的医用绷带及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhou Chaoyuan Inventor after: Liu Xiaochen Inventor after: Su Guobao Inventor after: Guo Xiaoliang Inventor after: Niu Shanshan Inventor before: Fu Xingqin |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160913 Address after: 453199 No. 88 health Road, Weihui, Henan, Xinxiang Applicant after: The First Affiliated Hospital of Xinxiang Medical University Address before: 644305 Yibin Province, Changning City, the leading town of Sichuan County, the village of the group of 2, No. 105, attached to No. 2 Applicant before: Fu Xingqin |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191128 Address after: 211500 No. 7 Zhufeng Road, Zhuzhen, Liuhe District, Nanjing City, Jiangsu Province Patentee after: Nanjing Zhuhai Biotechnology Co.,Ltd. Address before: 453199 No. 88 health Road, Weihui, Henan, Xinxiang Patentee before: The First Affiliated Hospital of Xinxiang Medical University |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161012 |